Related Experiment Videos
Fulminant hepatic failure related to omeprazole
V Jochem1, R Kirkpatrick, J Greenson
1Department of Gastroenterology, Ohio State University, Columbus.
The American Journal of Gastroenterology
|April 1, 1992
Abstract:
Omeprazole is a new hydrogen-potassium adenosine triphosphatase antagonist with indications for severe reflux esophagitis and Zollinger-Ellison syndrome. Side effects involving the liver have consisted of minimal elevations of hepatocellular enzymes with higher dosages. We present what we believe is the first reported case of fulminant hepatic failure related to omeprazole.